investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
To Develop a Yeast-Based Assay for Discovery of Drugs Transported by ABCB5
Michael Gottesman
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
To Develop a Yeast-Based Assay for Discovery of Drugs Transported by ABCB5
Related projects
Vinay Pathak
Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions
All cancers but non-melanoma skin cancer
John L. Cleveland
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics
All cancers but non-melanoma skin cancer
David M Hockenbery
Metabolism, Protein and miRNA Cross-Talk in Cell Cycle and Tumor Progression
All cancers but non-melanoma skin cancer
Xiongbin Lu
Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
All cancers but non-melanoma skin cancer
Weei-Chin Lin
The ATM/E2F1 Pathway in DNA Damage and Growth Control
All cancers but non-melanoma skin cancer
William Patrick Tansey
Transcription Control by the Ubiquitin-Proteasome System
All cancers but non-melanoma skin cancer
Peter R Parham
Interactions Between HLA Class I and Cytolytic Lymphocytes
All cancers but non-melanoma skin cancer
Ira Pastan
Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties
All cancers but non-melanoma skin cancer
Matthew L. Meyerson
Genome Characterization Center (GCC)
All cancers but non-melanoma skin cancer